Protagenic Therapeutics Faces Delisting Concerns
Ticker: PTIXW · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics might get delisted - big trouble ahead.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on January 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event date being January 22, 2025. The company, formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates potential issues with Protagenic Therapeutics' compliance with stock exchange listing requirements, which could lead to its shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can severely impact a company's stock price and liquidity.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer of the 8-K report
- January 22, 2025 (date) — Earliest event date reported
- January 29, 2025 (date) — Filing date of the 8-K
- Atrinsic, Inc. (company) — Former company name
- New Motion, Inc. (company) — Former company name
- MPLC, Inc. (company) — Former company name
FAQ
What is the specific reason for Protagenic Therapeutics' potential delisting?
The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard,' but the specific rule or standard is not detailed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on January 22, 2025.
What is the filing date of this 8-K report?
The 8-K report was filed on January 29, 2025.
What were some of Protagenic Therapeutics' former company names?
Protagenic Therapeutics was formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc.
In which state is Protagenic Therapeutics incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-01-29 16:01:40
Key Financial Figures
- $1.00 — ment to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listi
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-25-004143.txt ( ) — 256KB
- ptix-20250122.xsd (EX-101.SCH) — 4KB
- ptix-20250122_def.xml (EX-101.DEF) — 29KB
- ptix-20250122_lab.xml (EX-101.LAB) — 36KB
- ptix-20250122_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: January 29, 2025 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3